Dr. Mahmoud Aljurf is the Director of Adult Stem Cell Transplant and Cell Therapy Program and Deputy Director of the Oncology Center at King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia.
He received his M.D. degree in 1985 from the University of Jordan. Subsequently he completed residency training in Internal Medicine at Brigham and Women's Hospital, Harvard Medical School, and combined Hematology & Oncology Fellowships at Stanford University Medical Center. He also received a Masters in Public Health (MPH) from Johns Hopkins University and FRCPath degree from the United Kingdom.
Dr. Aljurf is American Board Certified in Internal Medicine, Medical Oncology, Hematology, Medical Management and Quality Assurance. Dr. Aljurf has published over 300 scientific papers, several book chapters and the Lead Editor for the EBMT/ESH book on “Congenital and Acquired Bone Marrow Failure” and Co-Editor for Springer Publisher book “Establishing a Hematopoietic Stem Cell Transplant Unit: A Practical Guide”.
He worked with his colleagues in the EMRO region in establishing the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) organization as a cooperative platform for physicians, scientists and healthcare workers from institutions in the WHO designated EMRO region with the goal of sharing experience, initiation of cooperative trials and establish common strategy to achieve optimization in the field of HSCT.
Dr. Aljurf is the Editor-in-Chief for the Elsevier journal “Hematology/Oncology and Stem Cell Therapy”.
He was the recipient of the American College of Physicians (ACP) Mastership Award for the year 2012 and the recipient of The Center for International Blood and Marrow Transplant Research (CIBMTR) Distinguished Service Award for the year 2018